Aclaris Therapeutics shares owned by Connor, Clark & Lunn Investment Management
Quarter-by-quarter ownership of Aclaris Therapeutics (ACRS) shares owned by Connor, Clark & Lunn Investment Management
from 13F filings
Historical chart of Connor, Clark & Lunn Investment Management investment in Aclaris Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Aclaris Therapeutics held by Connor, Clark & Lunn Investment Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Aclaris Therapeutics by Connor, Clark & Lunn Investment Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-03-31 | $125k | 101k | 1.24 |
| 2023-09-30 | $1.4M | 201k | 6.85 |
| 2023-06-30 | $2.2M | 211k | 10.37 |
| 2023-03-31 | $1.4M | 177k | 8.09 |
| 2022-12-31 | $265k | 17k | 15.75 |
| 2022-09-30 | $423k | 27k | 15.75 |
| 2020-09-30 | $81k | 32k | 2.57 |
More positions owned by Connor, Clark & Lunn Investment Management
View all positions for Connor, Clark & Lunn Investment Management